Galectin approach to lower covid transmission - Drug Development for clinical use
Alben Sigamani, Kevin H Mayo, Hana Chen-Walden, Surender Reddy, David Platt
doi: https://doi.org/10.1101/2022.11.09.22282151
Alben Sigamani
1Carmel Research Consultancy Pvt. Ltd., Bengaluru, Karnataka 560025, India
Kevin H Mayo
2Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, 6-155 Jackson Hall, 321 Church Street, Minneapolis, MN 55455, USA
Hana Chen-Walden
3Pharmalectin India Pvt. Ltd., Rangareddy, Telangana 500039, India
Surender Reddy
4Department of Pulomonology, ESIC Medical college and Hospital, Sanath Nagar, Hyderabad, Telangana 500038, India
David Platt
3Pharmalectin India Pvt. Ltd., Rangareddy, Telangana 500039, India
Posted November 10, 2022.
Galectin approach to lower covid transmission - Drug Development for clinical use
Alben Sigamani, Kevin H Mayo, Hana Chen-Walden, Surender Reddy, David Platt
medRxiv 2022.11.09.22282151; doi: https://doi.org/10.1101/2022.11.09.22282151
Subject Area
Subject Areas
- Addiction Medicine (390)
- Allergy and Immunology (705)
- Anesthesia (196)
- Cardiovascular Medicine (2876)
- Dermatology (245)
- Emergency Medicine (432)
- Epidemiology (12600)
- Forensic Medicine (10)
- Gastroenterology (810)
- Genetic and Genomic Medicine (4474)
- Geriatric Medicine (407)
- Health Economics (717)
- Health Informatics (2866)
- Health Policy (1057)
- Hematology (378)
- HIV/AIDS (907)
- Medical Education (418)
- Medical Ethics (115)
- Nephrology (465)
- Neurology (4232)
- Nursing (226)
- Nutrition (619)
- Oncology (2217)
- Ophthalmology (630)
- Orthopedics (255)
- Otolaryngology (322)
- Pain Medicine (270)
- Palliative Medicine (83)
- Pathology (489)
- Pediatrics (1182)
- Primary Care Research (485)
- Public and Global Health (6817)
- Radiology and Imaging (1501)
- Respiratory Medicine (906)
- Rheumatology (430)
- Sports Medicine (373)
- Surgery (475)
- Toxicology (59)
- Transplantation (204)
- Urology (175)